Jacqueline Neuhaus

发表

A. Lifson, Jacqueline Neuhaus, J. Arribas, 2010 .

A. Lifson, Jacqueline Neuhaus, J. Arribas, 2010, American journal of public health.

Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study.

J. Gatell, A. Phillips, B. Grund, 2008, The Journal of infectious diseases.

Haemoglobin and anaemia in the SMART study

A. Mocroft, Z. Fox, J. Lundgren, 2010, Antiviral therapy.

In silico thrombin generation: Plasma composition imbalance and mortality in human immunodeficiency virus

K. Brummel-Ziedins, J. Neaton, S. Emery, 2018, Research and practice in thrombosis and haemostasis.

Short communication: CD4 T cell declines occurring during suppressive antiretroviral therapy reflect continued production of Casp8p41.

S. Lewin, M. Plana, J. Neaton, 2014, AIDS research and human retroviruses.

Interleukin-6, High Sensitivity C-Reactive Protein, and the Development of Type 2 Diabetes Among HIV-Positive Patients Taking Antiretroviral Therapy

J. Pankow, J. Neaton, S. De Wit, 2014, Journal of acquired immune deficiency syndromes.

Changes in Inflammatory and Coagulation Biomarkers: A Randomized Comparison of Immediate versus Deferred Antiretroviral Therapy in Patients With HIV Infection

L. Kuller, H. Lane, B. Ledergerber, 2011, Journal of acquired immune deficiency syndromes.

Inflammation predicts changes in high-density lipoprotein particles and apolipoprotein A1 following initiation of antiretroviral therapy

L. Kuller, D. Cooper, F. Lampe, 2011, AIDS.

Hepatitis B and C Co-Infection Are Independent Predictors of Progressive Kidney Disease in HIV-Positive, Antiretroviral-Treated Adults

A. Mocroft, A. Szymczak, M. Bickel, 2012, PloS one.

N-terminal-proB-type natriuretic peptide predicts cardiovascular disease events in HIV-infected patients

L. Kuller, D. Duprez, J. Neaton, 2011, AIDS.

Risk of cancers during interrupted antiretroviral therapy in the SMART study

J. Neaton, A. Hatzakis, Jacqueline Neuhaus, 2007, AIDS.

Immediate Antiretroviral Therapy Reduces Risk of Infection-Related Cancer During Early HIV Infection.

M. Johnson, T. Wilkin, S. Pujari, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

HIV Replication, Inflammation, and the Effect of Starting Antiretroviral Therapy on Plasma Asymmetric Dimethylarginine, a Novel Marker of Endothelial Dysfunction

J. Lundgren, D. Duprez, J. Neaton, 2012, Journal of acquired immune deficiency syndromes.

Investigation of Efavirenz Discontinuation in Multi-ethnic Populations of HIV-positive Individuals by Genetic Analysis

H. Chu, R. Weinshilboum, A. Telenti, 2015, EBioMedicine.

Severity of Cardiovascular Disease Outcomes Among Patients With HIV Is Related to Markers of Inflammation and Coagulation

D. Duprez, J. Neaton, M. McKenna, 2014, Journal of the American Heart Association.

Incomplete ART adherence is associated with higher inflammation in individuals who achieved virologic suppression in the START study

A. Phillips, J. Lundgren, J. Neaton, 2019, Journal of the International AIDS Society.

Abstract 14731: Glyc A, a Novel Marker of Inflammation, Predicts Cardiovascular Events in HIV-Positive Patients: Results of SMART Study

J. Lundgren, D. Duprez, J. Neaton, 2014 .

Benefit of Early versus Deferred Antiretroviral Therapy on Progression of Liver Fibrosis among People with HIV in the START Randomized Trial

S. Emery, C. Stephan, A. Arenas-Pinto, 2019, Hepatology.

Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study

A. Mocroft, O. Kirk, M. Johnson, 2015, PLoS medicine.

Resumption of HIV replication is associated with monocyte/macrophage derived cytokine and chemokine changes: results from a large international clinical trial

M. Plana, A. Landay, Jacqueline Neuhaus, 2011, AIDS.

Platelet count kinetics following interruption of antiretroviral treatment

J. Lundgren, J. Baker, C. Somboonwit, 2013, AIDS.

Hyaluronic Acid Levels Predict Increased Risk of Non-Aids Death in Hepatitis-Coinfected Persons Interrupting Antiretroviral Therapy in the Smart Study

A. Mocroft, B. Clotet, V. Soriano, 2011, Antiviral therapy.

Frequent hepatitis B virus rebound among HIV–hepatitis B virus-coinfected patients following antiretroviral therapy interruption

A. Mocroft, B. Clotet, J. Lundgren, 2010, AIDS.

Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection

Lewis H Kuller, H. Clifford Lane, Bruno Ledergerber, 2008, PLoS medicine.

Risk of all-cause mortality associated with nonfatal AIDS and serious non-AIDS events among adults infected with HIV

A. Mocroft, D. Wentworth, B. Angus, 2010, AIDS.

Biomarkers and Bacterial Pneumonia Risk in Patients with Treated HIV Infection: A Case-Control Study

S. Emery, B. Angus, J. Baker, 2013, PLoS ONE.

Design of a Randomized Controlled Trial for Ebola Virus Disease Medical Countermeasures: PREVAIL II, the Ebola MCM Study.

Michael A Proschan, Joseph S Koopmeiners, Lori E Dodd, 2016, The Journal of infectious diseases.

Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection.

D. Jacobs, L. Kuller, D. Duprez, 2010, The Journal of infectious diseases.

Interleukin 6 Is a Stronger Predictor of Clinical Events Than High-Sensitivity C-Reactive Protein or D-Dimer During HIV Infection.

A. Phillips, J. Lundgren, J. Neaton, 2016, The Journal of infectious diseases.

Inflammation, Coagulation and Cardiovascular Disease in HIV-Infected Individuals

L. Kuller, H. Lane, B. Ledergerber, 2012, PloS one.

Episodic Antiretroviral Therapy Increases HIV Transmission Risk Compared With Continuous Therapy: Results of a Randomized Controlled Trial

C. Rietmeijer, B. Grund, G. Friedland, 2008, Journal of acquired immune deficiency syndromes.

HIV Replication Alters the Composition of Extrinsic Pathway Coagulation Factors and Increases Thrombin Generation

L. Kuller, D. Duprez, J. Neaton, 2013, Journal of the American Heart Association.

Soluble biomarkers and morbidity and mortality among people infected with HIV: summary of published reports from 1997 to 2010

Sean Emery, James D. Neaton, J. Neaton, 2010, Current opinion in HIV and AIDS.

Lipoprotein particle subclasses, cardiovascular disease and HIV infection.

L. Kuller, D. Cooper, F. Lampe, 2009, Atherosclerosis.

Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons.

Jacques Fellay, Amalio Telenti, Huldrych F Günthard, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Asymptomatic myocardial ischaemia in HIV-infected adults

W. El-Sadr, R. Prineas, B. Grund, 2008, AIDS.

D. Jacobs, D. Duprez, J. Neaton, 2017, Journal of acquired immune deficiency syndromes.

Biomarkers of inflammation, coagulation and microbial translocation in HIV/HCV co-infected patients in the SMART study.

A. Mocroft, J. Lundgren, D. Duprez, 2014, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Association of Suboptimal Antiretroviral Therapy Adherence With Inflammation in Virologically Suppressed Individuals Enrolled in the SMART Study

A. Phillips, J. Lundgren, J. Neaton, 2017, Open forum infectious diseases.

The Effect of Interrupted/Deferred Antiretroviral Therapy on Disease Risk: A SMART and START Combined Analysis

J. Lundgren, J. Neaton, S. Emery, 2018, The Journal of infectious diseases.

Adjudicated Morbidity and Mortality Outcomes by Age among Individuals with HIV Infection on Suppressive Antiretroviral Therapy

R. Paredes, A. Winston, J. Neaton, 2014, PloS one.

Relative risk of death in the SMART study.

A. Phillips, B. Grund, Jacqueline Neuhaus, 2009, Lancet. Infectious Diseases (Print).

Reply to Meijide et al.

T. Wilkin, Jacqueline Neuhaus, A. Babiker, 2017, Clinical Infectious Diseases.

Title : Benefit of early versus deferred antiretroviral therapy on progression of liver fibrosis among people with HIV in the START randomized trial

S. Emery, C. Stephan, A. Arenas-Pinto, 2018 .

Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection

B. Ledergerber, J. Neaton, S. Deeks, 2008 .

Severity of Cardiovascular Disease Outcomes Among Patients With HIV Is Related to Markers of Inflammation and Coagulation

D. Duprez, J. Neaton, M. McKenna, 2014, Journal of the American Heart Association.